1-(5-Carboxyindazol-1-yl)propan-2-ones as dual inhibitors of cytosolic phospholipase A₂α and fatty acid amide hydrolase: bioisosteric replacement of the carboxylic acid moiety

References

• Dennis EA, Cao J, Hsu YH, et al. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 2011;111:6130–85.
   PubMed Web of Science ®Google Scholar
• Leslie CC. Cytosolic phospholipase A2: physiological function and role in disease. J Lipid Res 2015;56:1386–402.
   PubMed Web of Science ®Google Scholar
• Di Marzo V. Endocannabinoids: synthesis and degradation. Rev Physiol Biochem Pharmacol 2008;160:1–24.
   PubMed Web of Science ®Google Scholar
• Fezza F, De Simone C, Amadio D, Maccarrone M. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system. Subcell Biochem 2008;49:101–32.
   PubMedGoogle Scholar
• Lehr M. Inhibitors of cytosolic phospholipase A2α as anti-inflammatory drugs. In: Levin JI, Laufer S, eds. Anti-inflammatory drug discovery. Cambridge: The Royal Society of Chemistry; 2012: 35–57
   Google Scholar
• Magrioti V, Kokotos G. Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010–present). Expert Opin Ther Pat 2013;23:333–44.
   PubMed Web of Science ®Google Scholar
• Ong WY, Farooqui T, Kokotos G, Farooqui AA. Synthetic and natural inhibitors of phospholipases A2: their importance for understanding and treatment of neurological disorders. ACS Chem Neurosci 2015;6:814–31.
   PubMed Web of Science ®Google Scholar
• Bisogno T, Maccarrone M. Latest advances in the discovery of fatty acid amide hydrolase inhibitors. Expert Opin Drug Discov 2013;8:509–22.
   PubMed Web of Science ®Google Scholar
• Lodola A, Castelli R, Mor M, Rivara S. Fatty acid amide hydrolase inhibitors: a patent review (2009–2014). Expert Opin Ther Pat 2015;25:1247–66.
   PubMed Web of Science ®Google Scholar
• Ludwig J, Bovens S, Brauch C, et al. Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2α. J Med Chem 2006;49:2611–20.
   PubMed Web of Science ®Google Scholar
• Hess M, Schulze Elfringhoff A, Lehr M. 1-(5-Carboxy- and 5-carbamoylindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2α: bioisosteric replacement of the carboxylic acid and carboxamide moiety. Bioorg Med Chem 2007;15:2883–91.
   PubMed Web of Science ®Google Scholar
• Drews A, Bovens S, Roebrock K, et al. 1-(5-Carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2α with reduced lipophilicity: synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activity. J Med Chem 2010;53:5165–78.
   PubMed Web of Science ®Google Scholar
• Forster L, Ludwig J, Kaptur M, et al. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase. Bioorg Med Chem 2010;18:945–52.
   PubMed Web of Science ®Google Scholar
• Zahov S, Drews A, Hess M, et al. (3-Biaryloxy-2-oxopropyl)indole-5-carboxylic acids and related compounds as dual inhibitors of human cytosolic phospholipase A2α and fatty acid amide hydrolase. Chem Med Chem 2011;6:544–9.
   Web of Science ®Google Scholar
• Schwarzkopf J, Sundermann T, Arnsmann M, et al. Inhibitors of cytosolic phospholipase A2α with carbamate structure: synthesis, biological activity, metabolic stability, and bioavailability. Med Chem Res 2014;23:5250–62.
   Web of Science ®Google Scholar
• Lima LM, Barreiro EJ. Bioisosterism: a useful strategy for molecular modification and drug design. Curr Med Chem 2005;12:23–49.
   PubMed Web of Science ®Google Scholar
• Sundermann T, Lehr M. Synthesis of 1-tetrazolylalkan-2-amines and -carbamates. Synth Commun 2014;44:1641–8.
   Google Scholar
• Hanekamp W, Lehr M. Determination of arachidonic acid by on-line solid-phase extraction HPLC with UV detection for screening of cytosolic phospholipase A2α inhibitors. J Chromatogr B Analyt Technol Biomed Life Sci 2012;900:79–84.
   PubMed Web of Science ®Google Scholar
• Holtfrerich A, Hanekamp W, Lehr M. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). Eur J Med Chem 2013;63:64–75.
   PubMed Web of Science ®Google Scholar
• Forster L, Schulze Elfringhoff A, Lehr M. High-performance liquid chromatographic assay with fluorescence detection for the evaluation of inhibitors against fatty acid amide hydrolase. Anal Bioanal Chem 2009;394:1679–85.
   PubMed Web of Science ®Google Scholar
• McKew JC, Foley MA, Thakker P, et al. Inhibition of cytosolic phospholipase A2α: hit to lead optimization. J Med Chem 2006;49:135–58.
   PubMed Web of Science ®Google Scholar
• Kathuria S, Gaetani S, Fegley D, et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 2003;9:76–81.
   PubMed Web of Science ®Google Scholar